Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes
about
Clinical perspectives of TRAIL: insights into central nervous system disordersRAGE mediates accelerated diabetic vein graft atherosclerosis induced by combined mechanical stress and AGEs via synergistic ERK activationLevels of circulating TNF-related apoptosis-inducing ligand in celiac diseaseIntranasal administration of recombinant TRAIL down-regulates CXCL-1/KC in an ovalbumin-induced airway inflammation murine modelCell-based therapies for diabetic complications.TRAIL modulates the immune system and protects against the development of diabetes.TNF-related apoptosis-inducing ligand promotes human preadipocyte proliferation via ERK1/2 activation.The Induction of Heme Oxygenase 1 Decreases Painful Diabetic Neuropathy and Enhances the Antinociceptive Effects of Morphine in Diabetic Mice.Serum TRAIL levels increase shortly after insulin therapy and metabolic stabilization in children with type 1 diabetes mellitus.Empirical redefinition of comprehensive health and well-being in the older adults of the United States.Inhibitory effect of natural anti-inflammatory compounds on cytokines released by chronic venous disease patient-derived endothelial cells.SOCS and diabetes--ups and downs of a turbulent relationship.Tumor Necrosis Factor Related Apoptosis Inducing Ligand (Trail) in endothelial response to biomechanical and biochemical stresses in arteries.The MDM2 inhibitor Nutlin-3 attenuates streptozotocin-induced diabetes mellitus and increases serum level of IL-12p40.Kinin B1 Receptor Deletion Affects Bone Healing in Type 1 Diabetic Mice.TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications.The long and winding TRAIL to weight loss.TRAIL reduces impaired glucose tolerance and NAFLD in the high-fat diet fed mouse.Survival of autoreactive T lymphocytes by microRNA-mediated regulation of apoptosis through TRAIL and Fas in type 1 diabetes.Circulating level of TRAIL concentration is positively associated with endothelial function and increased by diabetic therapy in the newly diagnosed type 2 diabetic patients.The levels of circulating TRAIL at the onset of type 1 diabetes are markedly decreased in patients with ketoacidosis and with the highest insulin requirement.Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease
P2860
Q26766570-BF6501F2-9785-443B-B916-90DE80498C29Q28482199-5E8BF8FA-CA5A-4F0C-A1AA-A19FB9C04D4FQ34445054-C9CEA122-5B23-4C65-87B6-852826A87F13Q34704284-C1738C29-AC66-45F1-81C8-61DCCD44529AQ35070554-D879C006-4986-4416-BD3E-827A42809495Q35155962-D104A6D4-0818-4EE8-BEC2-8B6FFAEBF524Q35774778-B90A8B47-58DD-4F68-9FBB-D54FA41E861CQ35885005-BB0ABA9B-FBCB-4E4E-AA62-BB54A4AC7CCCQ36053378-CDC265CC-A603-4E82-8488-F4C30DBE1F52Q36978136-3ED2F546-7CAC-406E-8F3E-709CAC1ABAC4Q37486658-BFD387A7-D98D-400F-8CAF-9B3032634B18Q38075516-620536B1-F0A5-463B-A32C-CD97FA4895C6Q38479846-DDD763FE-4B2A-4771-876E-C253C8BE4ACEQ39161098-F1D9414D-7E7D-4111-AEC3-9ED010324538Q40944950-68D74162-7A7F-4506-B6E1-2B0CCCA413D0Q41123139-C5EF83C0-6704-4793-ACB6-721F9ECEFA3DQ47301573-0F024140-2B1E-4ACC-A804-90378A479D40Q47372528-A9578E35-F7F6-49AC-998D-6929BD798703Q47611305-82A93187-D3DE-4F2C-89F8-AB577941E62DQ47819776-930BB86B-07DF-4234-83A0-1596D904394DQ47832405-70AD909A-4D82-475F-9CCE-C3F382DC3963Q58752270-26AACC9A-9B4F-41CD-9E8B-CB9F4B19B4D2
P2860
Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Treatment with recombinant tum ...... treptozotocin-induced diabetes
@ast
Treatment with recombinant tum ...... treptozotocin-induced diabetes
@en
type
label
Treatment with recombinant tum ...... treptozotocin-induced diabetes
@ast
Treatment with recombinant tum ...... treptozotocin-induced diabetes
@en
prefLabel
Treatment with recombinant tum ...... treptozotocin-induced diabetes
@ast
Treatment with recombinant tum ...... treptozotocin-induced diabetes
@en
P2093
P2860
P50
P356
P1433
P1476
Treatment with recombinant tum ...... treptozotocin-induced diabetes
@en
P2093
Barbara Toffoli
Claudio Celeghini
Maria Grazia di Iasio
P2860
P304
P356
10.2337/DB09-1771
P407
P577
2010-02-25T00:00:00Z